Analysis

Pharma Technology Focus – Issue 64

Pharma Technology Focus – Issue 64

September's top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business

September's top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business

How voice assistant technology could revolutionise clinical trials

How voice assistant technology could revolutionise clinical trials

Hard nut to crack: new trial brings new hope for children with peanut allergies

Hard nut to crack: new trial brings new hope for children with peanut allergies

Pharma Technology Focus – Issue 63

Pharma Technology Focus – Issue 63

Mining fungi: a fountain of new medicines?

Mining fungi: a fountain of new medicines?

Osteoporosis breakthrough: positive news in a field plagued by bad press

Osteoporosis breakthrough: positive news in a field plagued by bad press

1 in 5: why the UK pharma industry is going to court over spending caps

1 in 5: why the UK pharma industry is going to court over spending caps

August's top stories: Mylan launched anti-retroviral treatments, Fosun updated on $1.3bn takeover

August's top stories: Mylan launched anti-retroviral treatments, Fosun updated on $1.3bn takeover

Is Amazon gearing up to take on the US pharmacy market?

Is Amazon gearing up to take on the US pharmacy market?

Pharma Technology Focus – Issue 62

Pharma Technology Focus – Issue 62

Zika virus: an unlikely new anti-cancer candidate

Zika virus: an unlikely new anti-cancer candidate

New library building the LINC between pharmaceutical industry and academia

New library building the LINC between pharmaceutical industry and academia

July's top stories: Researchers found epithelial cells prevent Ebola, Mitsubishi agreed to buy NeuroDerm

July's top stories: Researchers found epithelial cells prevent Ebola, Mitsubishi agreed to buy NeuroDerm

Closing the US pharmaceutical industry’s growing skills gap

Closing the US pharmaceutical industry’s growing skills gap

PhRMA: resetting the conversation

PhRMA: resetting the conversation

Do healthcare cuts risk creating a ‘desert for innovation’ in the UK?

Do healthcare cuts risk creating a ‘desert for innovation’ in the UK?

Betting big on Gamma Delta T Cells

Betting big on Gamma Delta T Cells

Pharma Technology Focus – Issue 61

Pharma Technology Focus – Issue 61

Cystic fibrosis: searching for a breakthrough

Cystic fibrosis: searching for a breakthrough

US drug imports: a recipe for disaster?

US drug imports: a recipe for disaster?
cachename:Featurescachekey:rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_-2004945256